These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 9200475)
1. Expression of a biologically active recombinant mouse IL-1 receptor antagonist and its use in vivo to modulate aspects of the acute phase response. Grehan S; Uhlar CM; Sim RB; Herbert J; Whitehead AS J Immunol; 1997 Jul; 159(1):369-78. PubMed ID: 9200475 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of the major circulating precursors of proteins deposited in secondary amyloidosis by a recombinant mouse interleukin-1 receptor antagonist. Grehan S; Herbert J; Whitehead AS Eur J Immunol; 1997 Oct; 27(10):2593-9. PubMed ID: 9368615 [TBL] [Abstract][Full Text] [Related]
3. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo. Gabay C; Porter B; Fantuzzi G; Arend WP J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 and the acute-phase response: induction of mouse liver serum amyloid A mRNA by murine recombinant interleukin-1. Weinstein JA; Taylor JM J Trauma; 1987 Nov; 27(11):1227-32. PubMed ID: 3119866 [TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 receptor antagonist localization exclusively in non-parenchymal cells of the mouse liver. Rokita H; Kosz-Vnenchak M; Stalińska K; Stachura J Cytokine; 1997 Apr; 9(4):249-53. PubMed ID: 9112333 [TBL] [Abstract][Full Text] [Related]
6. IL-1 receptor antagonist affects the plasma protein response of Hep 3B cells to conditioned medium from lipopolysaccharide-stimulated monocytes. Damtew B; Rzewnicki D; Lozanski G; Kushner I J Immunol; 1993 May; 150(9):4001-7. PubMed ID: 7682588 [TBL] [Abstract][Full Text] [Related]
7. Acute phase induction of mouse serum amyloid P component. Correlation with other parameters of inflammation. Zahedi K; Whitehead AS J Immunol; 1989 Nov; 143(9):2880-6. PubMed ID: 2809211 [TBL] [Abstract][Full Text] [Related]
8. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993 [TBL] [Abstract][Full Text] [Related]
10. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis. Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477 [TBL] [Abstract][Full Text] [Related]
11. IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia. Calkins CM; Bensard DD; Shames BD; Pulido EJ; Abraham E; Fernandez N; Meng X; Dinarello CA; McIntyre RC J Endotoxin Res; 2002; 8(1):59-67. PubMed ID: 11981446 [TBL] [Abstract][Full Text] [Related]
12. Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts. Mühlberg T; Heberling HJ; Joba W; Schworm HD; Heufelder AE Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1018-28. PubMed ID: 9112998 [TBL] [Abstract][Full Text] [Related]
13. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis. Tam FW; Smith J; Cashman SJ; Wang Y; Thompson EM; Rees AJ Am J Pathol; 1994 Jul; 145(1):126-36. PubMed ID: 8030744 [TBL] [Abstract][Full Text] [Related]
14. Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury. Cho K; Pham TN; Crivello SD; Jeong J; Green TL; Greenhalgh DG Shock; 2004 Feb; 21(2):144-50. PubMed ID: 14752288 [TBL] [Abstract][Full Text] [Related]
16. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis. La E; Muga SJ; Locniskar MF; Fischer SM Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra). Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086 [TBL] [Abstract][Full Text] [Related]
18. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression. Carl VS; Gautam JK; Comeau LD; Smith MF J Leukoc Biol; 2004 Sep; 76(3):735-42. PubMed ID: 15218058 [TBL] [Abstract][Full Text] [Related]
19. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii. Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437 [TBL] [Abstract][Full Text] [Related]
20. The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes. Malyak M; Smith MF; Abel AA; Hance KR; Arend WP J Immunol; 1998 Aug; 161(4):2004-10. PubMed ID: 9712073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]